We note that although epidemiological studies have shown that risk of developing CRC in LS patients is correlated with MMR gene type, it remains unclear how to identify those patients in the genotype-defined cohorts that benefit from increased CRC surveillance. Here, MRC1 is linked to colorectal carcinoma.